We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-13.89%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$4.5B
AUM Growth
-$744M
Cap. Flow
+$158M
Cap. Flow %
3.51%
Top 10 Hldgs %
18.83%
Holding
605
New
48
Increased
192
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$39.6M
2
HES
Hess
HES
+$34.3M
3
PFE icon
Pfizer
PFE
+$14.5M
4
XYZ
Block Inc
XYZ
+$12.3M
5
KO icon
Coca-Cola
KO
+$12.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$31.4M
2
HMHC
Houghton Mifflin Harcourt Company
HMHC
+$19.3M
3
VMW
VMware, Inc
VMW
+$15.1M
4
CTRA
Coterra Energy
CTRA
+$15.1M
5
CSCO icon
Cisco
CSCO
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 29.9%
2 Healthcare 19.98%
3 Consumer Discretionary 10.77%
4 Financials 9.62%
5 Industrials 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RRX icon
476
Regal Rexnord
RRX
$12.2B
$297K 0.01%
+2,600
New +$331K
PCVX icon
477
Vaxcyte
PCVX
$8.07B
$294K 0.01%
14,200
– –
ADPT icon
478
Adaptive Biotechnologies
ADPT
$3.91B
$293K 0.01%
35,700
– –
MOS icon
479
The Mosaic Company
MOS
$7.44B
$289K 0.01%
6,000
+1,000
+20% +$61.3K
TWOU
480
DELISTED
2U Inc
TWOU
$285K 0.01%
869
– –
AFYA icon
481
Afya
AFYA
$1.25B
$282K 0.01%
28,191
+4,000
+17% +$49.4K
AFG icon
482
American Financial Group
AFG
$12.2B
$272K 0.01%
2,000
– –
RXRX icon
483
Recursion Pharmaceuticals
RXRX
$1.68B
$270K 0.01%
33,500
– –
ZNTL icon
484
Zentalis Pharmaceuticals
ZNTL
$352M
$266K 0.01%
9,800
– –
PSTH
485
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$265K 0.01%
13,250
– –
GL icon
486
Globe Life
GL
$14.3B
$264K 0.01%
2,700
-1,400
-34% -$137K
MEOH icon
487
Methanex
MEOH
$4.02B
$259K 0.01%
+6,600
New +$325K
SANA icon
488
Sana Biotechnology
SANA
$977M
$250K 0.01%
40,000
– –
CMRX
489
DELISTED
Chimerix, Inc.
CMRX
$249K 0.01%
121,000
– –
KZR
490
DELISTED
Kezar Life Sciences
KZR
$246K 0.01%
3,100
– –
ARQT icon
491
Arcutis Biotherapeutics
ARQT
$3.39B
$246K 0.01%
11,100
– –
RXDX
492
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$245K 0.01%
8,800
– –
ISEE
493
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$242K 0.01%
25,000
– –
FICO icon
494
Fair Isaac
FICO
$23.6B
$241K 0.01%
600
– –
BCYC
495
Bicycle Therapeutics
BCYC
$277M
$240K 0.01%
14,000
– –
VOYA icon
496
Voya Financial
VOYA
$9.08B
$240K 0.01%
+4,000
New +$257K
OWL icon
497
Blue Owl Capital
OWL
$7.81B
$235K 0.01%
23,460
– –
SEE
498
DELISTED
Sealed Air
SEE
$234K 0.01%
4,000
– –
FNF icon
499
Fidelity National Financial
FNF
$13.8B
$232K 0.01%
6,552
-1,560
-19% -$61K
TDOC icon
500
Teladoc Health
TDOC
$1.26B
$228K 0.01%
6,649
– –
18 19
20
21 22

Similar funds

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Erste Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Erste Asset Management held 605 positions worth $4.5B, down 14% from $5.24B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Erste Asset Management deployed $158M of net new capital in Q2 2022, opening 48 new positions and adding to 192 existing holdings. Its largest new stake was East-West Bancorp: 145,208 shares worth $9.42M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $31.4M trimmed.

  • Erste Asset Management's largest Q2 2022 buy was East-West Bancorp: 145,208 shares worth $9.42M.
  • Erste Asset Management added most to Netflix in Q2 2022, an estimated $39.6M increase.
  • Erste Asset Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $31.4M.
  • Erste Asset Management fully exited Houghton Mifflin Harcourt Company in Q2 2022, selling an estimated $19.3M.
  • Erste Asset Management's ten largest holdings make up 19% of its $4.5B portfolio in Q2 2022.
  • Erste Asset Management opened 48 new positions and closed 31 in Q2 2022.
  • Erste Asset Management's portfolio value fell 14% quarter-over-quarter to $4.5B.

Based on Erste Asset Management's 13F filing for Q2 2022, filed 26 Nov 2024.